Sleeve Gastrectomy May Be As Effective As Gastric Bypass Surgery in Resolving Type 2 Diabetes
Bariatric or weight
loss surgery has been determined to be an effective
weight loss tool, because the surgery can enable a
person to lose weight and maintain the weight loss
for a long period of time. Furthermore, the surgery
has been found to resolve a number of harmful
comorbidities, including type 2 diabetes. This is
especially true for gastric bypass surgery (GB).
Now, a recent study
has concluded that sleeve gastrectomy (SG) is as
successful at resolving type 2 diabetes as gastric
bypass surgery.
Sleeve gastrectomy (SG) is a form of weight loss surgery where a small stomach pouch, similar in shape to a banana, is created to restrict food intake. When first utilized, the surgery was commonly one stage of a two stage weight loss surgical procedure, with GB sometimes being the second stage.
An advantage of sleeve gastrectomy is that the gastrointestinal tract anatomy remains unaltered, unlike in GB. Therefore, some of the complications associated with GB -- and other procedures where the small intestine is modified -- are lessened. This means that SG could become a more viable option for treating type 2 diabetes than gastric bypass, provided the study referenced above is valid.
The above mentioned study was done in Israel. In the study, researchers looked at 41 obese type 2 diabetes patients who had bariatric surgery. The researchers followed 37 of the patients for twelve months. Nineteen of the patients underwent GB, and eighteen of the patients underwent SG. And as early as three months post-surgery, both the GB and the SG patients had similar healthy HbA1c levels: 6.37 ± 0.71% for the gastric bypass patients and 6.23 ± 0.69% for the SG patients.
SG is now considered to be an effective bariatric surgical procedure for weight loss. Indeed, past research has shown that "In severely obese and high-risk patients, laparoscopic sleeve gastrectomy provides superior total weight loss at 2 years."
And with good type 2 diabetes research results, SG will likely become a more utilized form of bariatric surgery. Offering this surgery could give a surgical bariatric center a competitive advantage.
Sleeve gastrectomy (SG) is a form of weight loss surgery where a small stomach pouch, similar in shape to a banana, is created to restrict food intake. When first utilized, the surgery was commonly one stage of a two stage weight loss surgical procedure, with GB sometimes being the second stage.
An advantage of sleeve gastrectomy is that the gastrointestinal tract anatomy remains unaltered, unlike in GB. Therefore, some of the complications associated with GB -- and other procedures where the small intestine is modified -- are lessened. This means that SG could become a more viable option for treating type 2 diabetes than gastric bypass, provided the study referenced above is valid.
The above mentioned study was done in Israel. In the study, researchers looked at 41 obese type 2 diabetes patients who had bariatric surgery. The researchers followed 37 of the patients for twelve months. Nineteen of the patients underwent GB, and eighteen of the patients underwent SG. And as early as three months post-surgery, both the GB and the SG patients had similar healthy HbA1c levels: 6.37 ± 0.71% for the gastric bypass patients and 6.23 ± 0.69% for the SG patients.
SG is now considered to be an effective bariatric surgical procedure for weight loss. Indeed, past research has shown that "In severely obese and high-risk patients, laparoscopic sleeve gastrectomy provides superior total weight loss at 2 years."
And with good type 2 diabetes research results, SG will likely become a more utilized form of bariatric surgery. Offering this surgery could give a surgical bariatric center a competitive advantage.
(Please leave a
comment by clicking on the "COMMENTS" link at the
lower right part of this blog post. SUBSCRIBE to
this blog by scrolling to the bottom of this page
and entering your email address.)
-------------------------------------------------------
Tags:
posted by Information Uncover at
4:05 PM
Comments:
Hi,
I hope all is well with you. Healthline just published an overview of a ConsumerReports’ evaluation of treatments and medications for Type II Diabetes. This is highly valuable information as it provides diabetes patients with an understanding of which medication is right for them.
You can see the overview of the report here: http://www.healthline.com/health/consumer-reports-type-2-diabetes
Our users have found our guide very useful, and I thought it would be a great resource for your page: http://stratbar.blogspot.com/2013/11/sleeve-gastrectomy-may-be-as-effective.html
I would really appreciate if you could review our request and consider adding this very useful information to your site.
Please let me know if you have any questions.
All the best,
Maggie Danhakl • Assistant Marketing Manager
p: 415-281-3124 f: 415-281-3199
Healthline • The Power of Intelligent Health
660 Third Street, San Francisco, CA 94107
www.healthline.com | @Healthline | @HealthlineCorp
About Us: corp.healthline.com
Post a Comment
Subscribe to Post Comments [Atom]
<< Home